BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35204691)

  • 1. Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells.
    Duarte D; Rêma A; Amorim I; Vale N
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
    Duarte D; Cardoso A; Vale N
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
    Duarte D; Nunes M; Ricardo S; Vale N
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines.
    Duarte D; Falcão SI; El Mehdi I; Vilas-Boas M; Vale N
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Strategies for Cancer Combat: Drug Combination Using Repurposed Drugs Induces Synergistic Growth Inhibition of MCF-7 Breast and HT-29 Colon Cancer Cells.
    Duarte D; Guerreiro I; Vale N
    Curr Issues Mol Biol; 2022 Oct; 44(10):4930-4949. PubMed ID: 36286050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells.
    Duarte D; Vale N
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33271968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines.
    Duarte D; Vale N
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells.
    Choupani J; Alivand MR; M Derakhshan S; Zaeifizadeh M; S Khaniani M
    J Cell Physiol; 2019 Jun; 234(6):9093-9104. PubMed ID: 30317622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of New Therapeutic Strategies to Combat Breast Cancer Using Drug Combinations.
    Correia A; Silva D; Correia A; Vilanova M; Gärtner F; Vale N
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30558247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer.
    Kurebayashi J; Nukatsuka M; Sonoo H; Uchida J; Kiniwa M
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):219-25. PubMed ID: 19455332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer.
    Fraguas-Sánchez AI; Fernández-Carballido A; Simancas-Herbada R; Martin-Sabroso C; Torres-Suárez AI
    Int J Pharm; 2020 Jan; 574():118916. PubMed ID: 31811927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Alone and in Combination of the Antiviral Saquinavir with 5-Fluorouracil in Prostate and Lung Cancer Cells.
    Pereira M; Vale N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
    Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
    Ruhnau J; Parczyk J; Danker K; Eickholt B; Klein A
    BMC Cancer; 2020 Jul; 20(1):617. PubMed ID: 32615946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
    Qu H; Fang L; Duan L; Long X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
    Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
    Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
    Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.